Denali Therapeutics Inc. (DNLI) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$20.17
Day's range
$21.75

Denali Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 13.03 M $250.26 M   2.51% 7.43%
BAILLIE GIFFORD & CO 05/08/2026 12.07 M $231.68 M   -1.99% 6.88%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 8.52 M $163.57 M   17.44% 4.86%
TEMASEK HOLDINGS (PRIVATE) LTD 05/12/2026 7.01 M $134.65 M   0.00% 4.00%
STATE STREET CORP 05/15/2026 6.27 M $120.42 M   0.14% 3.57%
05/15/2026 6.15 M $118.04 M   100.00% 3.50%
05/08/2026 6.12 M $117.51 M   100.00% 3.49%
FMR LLC 05/15/2026 4.58 M $87.85 M   -24.96% 2.61%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 4.43 M $85.10 M   -11.06% 2.53%
GOLDMAN SACHS GROUP INC 05/15/2026 4.41 M $84.62 M   14.90% 2.51%
BAKER BROS. ADVISORS LP 05/15/2026 3.73 M $71.65 M   0.00% 2.13%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 3.73 M $71.58 M   7.78% 2.12%
HOLOCENE ADVISORS, LP 05/15/2026 3.20 M $61.35 M   1.35% 1.82%
ALLIANCEBERNSTEIN L.P. 05/15/2026 2.89 M $47.77 M   -18.67% 1.65%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 2.69 M $51.69 M   13.39% 1.53%
UBS GROUP AG 05/05/2026 2.57 M $49.37 M   6.93% 1.47%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 2.56 M $48.44 M   92.53% 1.46%
CAPITAL RESEARCH GLOBAL INVESTORS 05/13/2026 2.51 M $48.28 M   -32.57% 1.43%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 2.46 M $47.31 M   -37.07% 1.40%
FISHER ASSET MANAGEMENT, LLC 05/05/2026 2.44 M $46.79 M   -5.89% 1.39%
CRESTLINE MANAGEMENT, LP 05/15/2026 2.21 M $42.45 M   -21.35% 1.26%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 1.94 M $37.27 M   125.95% 1.11%
LYNX1 CAPITAL MANAGEMENT LP 05/04/2026 1.88 M $36.10 M   8.14% 1.07%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 1.87 M $35.93 M   3,490.94% 1.07%
ABRDN PLC 04/29/2026 1.85 M $35.61 M   -8.78% 1.06%
CASDIN CAPITAL, LLC 05/15/2026 1.84 M $35.33 M   0.00% 1.05%
VESTAL POINT CAPITAL, LP 05/15/2026 1.77 M $34.05 M   281.36% 1.01%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 1.48 M $28.39 M   -2.99% 0.84%
SIREN, L.L.C. 05/14/2026 1.40 M $26.81 M   0.00% 0.80%
06/12/2026 1.36 M $26.11 M   107.09% 0.78%
NORTHERN TRUST CORP 05/14/2026 1.31 M $25.16 M   9.24% 0.75%
MILLENNIUM MANAGEMENT LLC 05/15/2026 1.26 M $24.15 M   240.20% 0.72%
FORESITE CAPITAL MANAGEMENT VI LLC 05/15/2026 1.21 M $23.23 M   21.00% 0.69%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.21 M $23.18 M   0.58% 0.69%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.13 M $21.78 M   21.67% 0.65%
MORGAN STANLEY 05/15/2026 1.10 M $21.21 M   -9.44% 0.63%
CANDRIAM S.C.A. 04/30/2026 1.10 M $21.12 M   -5.70% 0.63%
ARTISAN PARTNERS LIMITED PARTNERSHIP 05/13/2026 1.10 M $21.11 M   100.00% 0.63%
MARSHALL WACE, LLP 05/15/2026 991.27 K $19.03 M   29.77% 0.57%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 949.70 K $18.23 M   100.00% 0.54%
AMERICAN CENTURY COMPANIES INC 05/15/2026 935.69 K $17.97 M   146.85% 0.53%
BANK OF NEW YORK MELLON CORP 05/05/2026 768.04 K $14.75 M   0.78% 0.44%
CLEARSTEAD ADVISORS, LLC 05/06/2026 737.99 K $14.17 M   100.00% 0.42%
CERCANO MANAGEMENT LLC 05/13/2026 625.00 K $12.00 M   0.00% 0.36%
MASTERS CAPITAL MANAGEMENT LLC 05/15/2026 600.00 K $11.52 M   -40.00% 0.34%
ENSIGN PEAK ADVISORS, INC 05/13/2026 515.72 K $9.90 M   0.00% 0.29%
SEGALL BRYANT & HAMILL, LLC 05/22/2026 510.54 K $9.80 M   -4.93% 0.29%
STEMPOINT CAPITAL LP 05/18/2026 426.56 K $8.19 M   1.79% 0.24%
WOODLINE PARTNERS LP 05/15/2026 364.08 K $6.99 M   219.14% 0.21%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 346.36 K $6.65 M   -23.03% 0.20%

Denali Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 345 institutional investors and hedge funds held shares of Denali Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 13.03 M

BAILLIE GIFFORD & CO: 12.07 M

T. Rowe Price Investment Management, Inc.: 8.52 M

Temasek Holdings (Private) Ltd: 7.01 M

STATE STREET CORP: 6.27 M

FMR LLC: 4.58 M

84.01% of Denali Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 171.67 M shares in the last 24 months. This purchase volume represents approximately $3.66 B in transactions.